References
- Spinillo A, Tenti P, Zappatore R, De Seta F, Silini E, Guaschino S. Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol 1993; 48: 210–3
- Tay S K, Jenkins D, Maddox O, Campion M, Singer A. Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynecol 1987; 94: 10–5
- McArdle J P, Muller K. Quantitative assessment of Langerhans' cells in human cervical intraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol 1986; 154: 509–15
- Hawthorn R JS, Murdoch J B, MacLean A B, MacKie R M. Langerhans' cells and subtypes of human papillo-mavirus in cervical intraepithelial neoplasia. BMJ 1988; 297: 643–6
- Nakano T, Oka K, Arai T, Morita S, Tsunemoto H. Prognostic significance of Langerhans' cells infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med 1989; 113: 507–11
- Ferluga D, Vodovnik A, Luzar B, Cor A, Perkovit T, Gale N, KambiE V. Langerhans and other immuno-competent cells in vocal cord epithelial hyperplastic lesions of patients with chronic laryngitis. Acta Otolaryngol (Stockh) 1997; Suppl 527: 82–6
- Morris H HB, Gatter K C, Sykes G, Casemore V, Mason D Y. Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynecol 1983; 90: 412–20
- Gale N, Poljak M, Kambič V, Ferluga D, Fischinger J. Laryngeal papillomatosis: molecular, histopathological, and clinical evaluation. Virchows Arch 1994; 425: 291–5
- Lehtinen M, Rantala I, Toivonen A, Luoto H, Aine R, Lauslahti K, Ylaoutinen A, Rommpanen U, Paavonen J. Depletion of Langerhans cells in cervical HPV infection is associated with replication virus. APMIS 1993; 101: 883–7
- Kambič V, Gale N. Epithelial hyperplastic lesions of the larynx. Elsevier, Amsterdam 1995
- Poljak M, Orlowska J, Cerar A. Human papillo-mavirus infection in esophageal squamous cell papillomas: a study of 29 lesions. Anticancer Res 1995; 15: 965–70
- Brachman D G. Molecular biology of head and neck cancer. Semin Oncol 1994; 21: 320–9
- Bergfelt L. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study. Acta Derm Venereol (Stockh) 1993; Suppl 180: 7–37
- McKerrow K J, Hawthorn R J, Thompson W. An investigation of circulating and in situ lymphocyte subsets and Langerhans cells in the skin and cervix of patients with chronic renal failure. Br J Dermatol 1989; 120: 745–55
- Thompson A C, Griffin N. Langerhans cells in normal and pathological vocal cord mucosa. Acta Otolaryngol (Stockh) 1995; 115: 830–2
- van Rensburg E J, van Heerden W FP, Raubenheimer E J. Langerhans cells and human papillomaviruses in oesophageal and laryngeal carcinomas. In Vivo 1993; 7: 229–32
- zur Hansen H. Viruses in human cancer. Science 1991; 254: 1167–73
- Clark L J, MacKenzie K, Kenneth Parkinson E. Elevated levels of the p53 tumour suppressor protein in the basal layer of recurrent laryngeal papillomas. Clin Oncol 1993; 18: 63–5
- Li X, Coffino P H. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol 1996; 70: 4509–16
- Lane S, Wells M. Human papillomaviruses, p53, and cervical neoplasia (Editorial). J Pathol 1994; 172: 299–300